Successful treatment of multidrug-resistant <i>Escherichia coli</i> bacteremia with tigecycline in an acute myeloid leukemia child
TURKISH JOURNAL OF PEDIATRICS, cilt.54, sa.1, ss.59-60, 2012 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 54 Sayı: 1
- Basım Tarihi: 2012
- Dergi Adı: TURKISH JOURNAL OF PEDIATRICS
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.59-60
- İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır
Özet
Ozdemir H, Ciftci E, Karbuz A, Oktay G, Aysev D, Yavuz G, Ince E. Successful treatment of multidrug-resistant Escherichia coli bacteremia with tigecycline in an acute myeloid leukemia child. Turk J Pediatr 2012; 54: 59-60. The multidrug-resistant bacterial infections cause high mortality in immunocompromised patients because of the limited antibacterial choices. Tigecycline, first member of the glycylcyclines, has in vitro activity against a wide variety of organisms, including multidrug-resistant pathogens; however, it has not yet been approved for use in children. Herein, we report a nine-year-old girl with acute myeloid leukemia who was treated successfully with tigecycline due to multidrug-resistant Escherichia coli bacteremia.